SOURCE: Cambridge Healthtech Institute

February 16, 2007 12:44 ET

Strategic Planning for Discovery, Development and Clinical Operations in China, India and Other Emerging Regions

NEEDHAM, MA -- (MARKET WIRE) -- February 16, 2007 -- The Pharmaceutical Strategy Series (PSS), a division of Cambridge Healthtech Institute, posted details for its Global R&D Congress, May 15-16, 2007, Park Hyatt Hotel in Philadelphia, PA. Speakers and delegates from PSS's annual China and India conferences, as well as those involved in projects in Asia, Russia, Eastern Europe and Latin America, will discuss the opportunities and challenges of drug discovery and development in emerging regions.

"We are extremely pleased to present this conference to the industry," said Micah Lieberman, Conference Director for the Pharmaceutical Strategy Series and conference chairperson. "PSS conducted months of research and interviews with R&D executives; and based on our findings, we've developed a comprehensive event for bio/pharmaceutical companies to successfully expand and/or develop their R&D operations overseas. Basic research and discovery, preclinical development, and clinical operations will be carefully reviewed so our delegates' companies can start reaping the full benefits of outsourcing R&D in Asia."

The Global R&D Congress brings together an impressive roster of speakers representing US FDA, Merck, Wyeth, Biogen Idec, Bristol-Myers Squibb, Johnson & Johnson, to name a few, who will participate in case studies and panel discussions. Participants will attend a complimentary pre-conference tutorial, Planning a Global Strategy Around Intellectual Property Law: IP Barriers, and Trends, to be led by Greg Kalbaugh, US-India Business Council and Mak Jawadekar, Ph.D., Pfizer.

More on the Global R&D Congress can be found at

About the Pharmaceutical Strategy Series

The Pharmaceutical Strategy Series (PSS) is a division of Cambridge Healthtech Institute. PSS programs have been designed to help the R&D leaders and corporate executives assess business opportunities, enhance corporate value and forecast the economic and regulatory landscape within the rapidly changing pharmaceutical & biotechnology industries. PSS chooses the most topical issues to cover, based largely on advice given by the PSS Advisory Board. The Advisory Board is comprised of decision-makers at most of the world's leading pharmaceutical companies. Presentations in each Executive Forum will give you the ideas, information, and resources you need to make faster and smarter decisions.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute's renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US, including the Molecular Medicine Tri-Conference, Beyond Genome, PepTalk: The Protein Information Week, World Pharmaceutical Congress and the newly acquired Bio-IT World Conference & Expo. The company strives to develop quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. Leading researchers and business experts from top pharmaceutical, biotech and academic organizations present their most current findings in a forum that features panel discussions and audience participation. Over the past 14 years, CHI has produced more than 600 conferences, attracting more than 50,000 attendees from around the world.

Contact Information

  • Contact:
    Lisa Scimemi
    Cambridge Healthtech Institute
    Email Contact